Andere Sprachen AlloVir, Inc.

Aktien

A2QAMR

US0198181036

ALVR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 27.06.2024			% 5 Tage	% 1. Jan.
0,78 ^USD	+2,73 %		+5,53 %	+14,74 %

11.06.	AlloVir, Inc. schließt Vereinbarung zur Beendigung des Untermietverhältnisses mit AMAG Pharmaceuticals, Inc. ab	CI
13.05.	AlloVir, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc	11.06.
AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
North American Morning Briefing : Markets on Hold -2-	20.03.
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR	19.03.
ALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVR	18.03.
AlloVir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15.03.
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	15.03.
ALVR DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR	14.03.
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm	14.03.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir	13.03.
North American Morning Briefing : Stock Futures -2-	13.03.
ALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR	12.03.
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR	12.03.
ROSEN, A LEADING NATIONAL FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR	09.03.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR	07.03.
Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky	06.03.
ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR	05.03.
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir	05.03.
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR	03.03.
SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AlloVir, Inc.

Aktien

A2QAMR

US0198181036

ALVR

Andere Sprachen

Filter